P24864 (CCNE1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 142.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: G1/S-specific cyclin-E1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 410 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Essential for the control of the cell cycle at the G1/S (start) transition. Ref.3 |
| Subunit structure | Interacts with a member of the CDK2/CDK protein kinases to form a serine/threonine kinase holoenzyme complex. The cyclin subunit imparts substrate specificity to the complex. Found in a complex with CDK2, CABLES1 and CCNA1 By similarity. Part of a complex consisting of UHRF2, CDK2 and CCNE1. Interacts directly with UHRF2; the interaction ubiquitinates CCNE1 and appears to occur independently of CCNE1 phosphorylation. Ref.13 Ref.17 |
| Subcellular location | |
| Tissue specificity | Highly expressed in testis and placenta. Low levels in bronchial epithelial cells. Ref.11 |
| Post-translational modification | Phosphorylation of Thr-395 by GSK3 and of Ser-399 by CDK2 accelerates degradation via the ubiquitin proteasome pathway. Ubiquitinated by UHRF2; appears to occur independently of phosphorylation. Ref.17 |
| Sequence similarities | Belongs to the cyclin family. Cyclin E subfamily. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BRCA1 | P38398 | 2 | EBI-519526,EBI-349905 | |
| CDK2 | P24941 | 10 | EBI-519526,EBI-375096 | |
| CDKN1A | P38936 | 7 | EBI-519526,EBI-375077 | |
| CDKN1B | P46527 | 6 | EBI-519526,EBI-519280 | |
| UHRF2 | Q96PU4 | 4 | EBI-519526,EBI-625304 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform E1L (identifier: P24864-1) Also known as: E-L; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform E1S (identifier: P24864-2) The sequence of this isoform differs from the canonical sequence as follows: 154-196: Missing. | ||||||
| Note: Lacks 49 residues within the cyclin box and cannot complex with CDK2. | ||||||
| Isoform 3 (identifier: P24864-3) Also known as: E-S; The sequence of this isoform differs from the canonical sequence as follows: 1-15: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 410 | 410 | G1/S-specific cyclin-E1 | PRO_0000080449 | |||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 77 | 1 | Phosphothreonine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 103 | 1 | Phosphoserine Ref.14 Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 387 | 1 | Phosphoserine Ref.12 Ref.14 Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 395 | 1 | Phosphothreonine; by GSK3 Ref.10 Ref.12 Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 399 | 1 | Phosphoserine; by CDK2 Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 15 | 15 | Missing in isoform 3. | VSP_037381 | |||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 154 – 196 | 43 | Missing in isoform E1S. | VSP_001253 | |||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 9 | 1 | D → K no nucleotide entry Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 109 – 111 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 113 – 123 | 11 | |||||||||||||||||||||||||||||||||||||||||||||
| Turn | 124 – 126 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 133 – 136 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 142 – 158 | 17 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 163 – 179 | 17 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 185 – 187 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 188 – 203 | 16 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 210 – 215 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Turn | 216 – 219 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 223 – 236 | 14 | |||||||||||||||||||||||||||||||||||||||||||||
| Turn | 237 – 239 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 246 – 257 | 12 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 265 – 267 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 272 – 287 | 16 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 289 – 293 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 296 – 306 | 11 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 310 – 316 | 7 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 321 – 341 | 21 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 354 – 359 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 366 – 370 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast." Lew D.J., Dulic V., Reed S.I. Cell 66:1197-1206(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [2] | "Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family." Koff A., Cross F., Fisher A., Schumacher J., le Guellec K., Philippe M., Roberts J.M. Cell 66:1217-1228(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [3] | "Human cyclin E, a nuclear protein essential for the G1-to-S phase transition." Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Mol. Cell. Biol. 15:2612-2624(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS E1L AND 3), FUNCTION, SUBCELLULAR LOCATION, ALTERNATIVE SPLICING. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM E1L). Tissue: Placenta. |
| [5] | NIEHS SNPs program Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM E1L). Tissue: Placenta. |
| [7] | "Regulation of cyclin E transcription by E2Fs and retinoblastoma protein." Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., Sardet C., Weinberg R.A. Oncogene 12:1173-1180(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-42. |
| [8] | "Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors." Li H., Lahti J.M., Valentine M., Saito M., Reed S.I., Look A.T., Kidd V.J. Genomics 32:253-259(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 281-370. |
| [9] | "Alternative splicing of human cyclin E." Sewing A., Roenicke V., Buerger C., Funk M., Mueller R. J. Cell Sci. 107:581-588(1994) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING. |
| [10] | "Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E." Won K.A., Reed S.I. EMBO J. 15:4182-4193(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-395. |
| [11] | "Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins." Zariwala M., Liu J., Xiong Y. Oncogene 17:2787-2798(1998) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [12] | "Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation." Welcker M., Singer J., Loeb K.R., Grim J., Bloecher A., Gurien-West M., Clurman B.E., Roberts J.M. Mol. Cell 12:381-392(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT THR-77; SER-387; THR-395 AND SER-399. |
| [13] | "NIRF induces G1 arrest and associates with Cdk2." Li Y., Mori T., Hata H., Homma Y., Kochi H. Biochem. Biophys. Res. Commun. 319:464-468(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH UHRF2 AND CDK2. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; SER-387 AND THR-395, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [16] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103 AND SER-387, MASS SPECTROMETRY. |
| [17] | "NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor." Mori T., Ikeda D.D., Fukushima T., Takenoshita S., Kochi H. Cell Cycle 10:3284-3299(2011) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION, INTERACTION WITH UHRF2. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M74093 mRNA. No translation available. M73812 mRNA. No translation available. AK291549 mRNA. Translation: BAF84238.1. AF518727 Genomic DNA. Translation: AAM54043.1. BC035498 mRNA. Translation: AAH35498.1. X95406 Genomic DNA. Translation: CAA64687.1. X95406 Genomic DNA. Translation: CAA64688.1. AH003247 Genomic DNA. Translation: AAA83269.1. | ||||||||||||
| IPI | IPI00031077. IPI00376965. IPI01012689. | ||||||||||||
| PIR | A40270. | ||||||||||||
| RefSeq | NP_001229.1. NM_001238.2. | ||||||||||||
| UniGene | Hs.244723. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P24864. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-149N. | ||||||||||||
| IntAct | P24864. 12 interactions. | ||||||||||||
| MINT | MINT-1514839. | ||||||||||||
| STRING | 9606.ENSP00000262643. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P24864. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 3041657. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P24864. | ||||||||||||
| PRIDE | P24864. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 898. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000262643; ENSP00000262643; ENSG00000105173. ENST00000444983; ENSP00000410179; ENSG00000105173. | ||||||||||||
| GeneID | 898. | ||||||||||||
| KEGG | hsa:898. | ||||||||||||
| UCSC | uc002nsn.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 898. | ||||||||||||
| GeneCards | GC19P030302. | ||||||||||||
| HGNC | HGNC:1589. CCNE1. | ||||||||||||
| HPA | CAB000308. CAB016682. HPA018169. | ||||||||||||
| MIM | 123837. gene. | ||||||||||||
| neXtProt | NX_P24864. | ||||||||||||
| PharmGKB | PA96. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5024. | ||||||||||||
| HOGENOM | HOG000231743. | ||||||||||||
| HOVERGEN | HBG050834. | ||||||||||||
| InParanoid | P24864. | ||||||||||||
| KO | K06626. | ||||||||||||
| OMA | PLLQPKM. | ||||||||||||
| PhylomeDB | P24864. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | bard1pathway. BARD1 signaling events. foxm1pathway. FOXM1 transcription factor network. prlsignalingeventspathway. Signaling events mediated by PRL. | ||||||||||||
| Reactome | REACT_115566. Cell Cycle. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P24864. | ||||||||||||
| Bgee | P24864. | ||||||||||||
| CleanEx | HS_CCNE1. | ||||||||||||
| Genevestigator | P24864. | ||||||||||||
| GermOnline | ENSG00000105173. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.472.10. 2 hits. | ||||||||||||
| InterPro | IPR013763. Cyclin-like. IPR014400. Cyclin_A/B/D/E. IPR004367. Cyclin_C-dom. IPR006671. Cyclin_N. [Graphical view] | ||||||||||||
| Pfam | PF02984. Cyclin_C. 1 hit. PF00134. Cyclin_N. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF001771. Cyclin_A_B_D_E. 1 hit. | ||||||||||||
| SMART | SM00385. CYCLIN. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF47954. Cyclin_like. 1 hit. | ||||||||||||
| PROSITE | PS00292. CYCLINS. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P24864. | ||||||||||||
| ChEMBL | CHEMBL3617. | ||||||||||||
| EvolutionaryTrace | P24864. | ||||||||||||
| GenomeRNAi | 898. | ||||||||||||
| NextBio | 3708. | ||||||||||||
| PMAP-CutDB | P24864. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CCNE1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P24864 Secondary accession number(s): A8K684 Q9UD21 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
